Peter Christian Warnke to Thymidine Kinase
This is a "connection" page, showing publications Peter Christian Warnke has written about Thymidine Kinase.
Connection Strength
0.155
-
Adenovirus-mediated gene therapy with sitimagene ceradenovec followed by intravenous ganciclovir for patients with operable high-grade glioma (ASPECT): a randomised, open-label, phase 3 trial. Lancet Oncol. 2013 Aug; 14(9):823-33.
Score: 0.117
-
Gene therapy for glioblastoma [correction of gliobestome] multiform: in vivo tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. J Mol Med (Berl). 1997 Apr; 75(4):300-4.
Score: 0.038